{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:40:29Z","timestamp":1760060429832,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-77"],"award-info":[{"award-number":["ORF-2025-77"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: Investigate patient characteristics, treatments used, treatment response, and factors associated with outcomes when managing SE in a pediatric population admitted to the emergency department (ED). Methods: This retrospective observational study included pediatric patients (age \u2264 18 years) with SE admitted to the ED at King Khalid University Hospital between 2015 and 2023. SE and refractory SE (RSE) were diagnosed according to the American Epilepsy Society (AES) definitions. The data included demographics, home medications, treatment sequences, medication dosing, and clinical outcomes. To assess appropriateness, the administered doses were compared with the AES standards for pediatric patients. Results: The study included 487 episodes of SE. The mean patient age was 6.1 \u00b1 4.1 years, and most patients were males (57.3%) with a history of epilepsy (74.1%). Benzodiazepines (BDZs) were administered first in 83.0% of cases, with a 10.9% success rate, whereas anti-seizure medications (ASMs) were administered first in 17.0% of cases, with a 66.3% success rate (p &lt; 0.0001). Surprisingly, medications administered at appropriate doses during the first round were significantly less effective compared to those that were underdosed (18.2% vs. 28.4%; p = 0.0222), mainly because of poor response to BDZs. Younger patients and those who received BDZs on their first medication round had higher hospital admission rates. Conclusions: ASMs were more effective than BDZs in managing pediatric patients with SE, regardless of the dosing precision. These findings point toward the adoption of personalized treatment strategies and may warrant early initiation of ASMs. National multicenter studies are needed to define a standardized pediatric SE protocol.<\/jats:p>","DOI":"10.3390\/jcm14175940","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:31:26Z","timestamp":1755865886000},"page":"5940","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Response in Pediatric Patients with Status Epilepticus: A Retrospective Observational Study from Saudi Arabia"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3792-4106","authenticated-orcid":false,"given":"Omar A.","family":"Almohammed","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"},{"name":"Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-0094","authenticated-orcid":false,"given":"Aseel","family":"Alsuwayegh","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Services, King Saud University Medical City, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader M.","family":"Alhadhrami","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz A.","family":"Alqarni","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-3779","authenticated-orcid":false,"given":"Marwan A.","family":"Alrasheed","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan M.","family":"Alghadeer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.2147\/IJGM.S391090","article-title":"Epidemiology and Risk Factors of Convulsive Status Epilepticus Patients Admitted in the Emergency Department of Tertiary Hospital in Mogadishu, Somalia","volume":"15","author":"Sidow","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.nrl.2021.09.009","article-title":"Status epilepticus-Therapeutic management at the pediatric emergency department","volume":"39","author":"Valente","year":"2024","journal-title":"Neurologia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.51847\/tOl3Efkk8d","article-title":"Status Epilepticus in Pediatric Patients in Saudi Arabia: A Systematic Review","volume":"13","author":"Alanazi","year":"2022","journal-title":"Arch. Pharm. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2018.06.004","article-title":"Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers","volume":"86","author":"Vasquez","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","article-title":"Treatment of community-onset, childhood convulsive status epilepticus: A prospective, population-based study","volume":"7","author":"Chin","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus","volume":"75","author":"Jackson","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1393","DOI":"10.1212\/WNL.0000000000200912","article-title":"Mortality, Disability, and Prognostic Factors of Status Epilepticus","volume":"99","author":"Choi","year":"2022","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.seizure.2023.07.022","article-title":"Early and established status epilepticus: The impact of timing of intervention, treatment escalation and dosing on outcome","volume":"111","author":"Jindal","year":"2023","journal-title":"Seizure"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1111\/epi.17043","article-title":"Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus","volume":"62","author":"Sheehan","year":"2021","journal-title":"Epilepsia"},{"key":"ref_11","first-page":"e4471","article-title":"Course and Outcome of Children with Convulsive Status Epilepticus Admitted to a Pediatric Intensive Care Unit","volume":"11","author":"Chegondi","year":"2019","journal-title":"Cureus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acem.13811","article-title":"Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial","volume":"26","author":"Sathe","year":"2019","journal-title":"Acad. Emerg. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PEC.0b013e318196ea6e","article-title":"Emergency management of pediatric convulsive status epilepticus: A multicenter study of 542 patients","volume":"25","author":"Lewena","year":"2009","journal-title":"Pediatr. Emerg. Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yebeh.2014.06.008","article-title":"A retrospective observational study of current treatment for generalized convulsive status epilepticus","volume":"37","author":"Langer","year":"2014","journal-title":"Epilepsy Behav."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): A double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.seizure.2019.10.004","article-title":"A tiered strategy for investigating status epilepticus","volume":"75","author":"Craig","year":"2020","journal-title":"Seizure"},{"key":"ref_17","first-page":"26","article-title":"The etiology and risk factors of convulsive status epilepticus in pediatric patients of tertiary center in Saudi Arabia","volume":"26","author":"Alyoubi","year":"2021","journal-title":"Neurosci. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5144\/0256-4947.2017.455","article-title":"Retrospective review of pediatric status epilepticus in 116 Saudi patients: Predictors of outcome","volume":"37","author":"Hommady","year":"2017","journal-title":"Ann. Saudi Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.4103\/0972-2327.128647","article-title":"Refractory status epilepticus","volume":"17","author":"Singh","year":"2014","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_20","unstructured":"National Institute for Health and Care Excellence (NICE) (2025, August 10). Epilepsies in Children, Young People and Adults. Available online: https:\/\/www.nice.org.uk\/guidance\/ng217."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"A68","DOI":"10.1016\/j.jval.2016.03.217","article-title":"Drug Utilization Evaluation Of Antiepileptic Drugs In Pediatric Population At A Secondary Care Hospital","volume":"19","author":"Nalluri","year":"2016","journal-title":"Value Health"},{"key":"ref_22","first-page":"264","article-title":"Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan","volume":"21","author":"Gharaibeh","year":"2016","journal-title":"Neurosci. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/epi.18216","article-title":"Community-onset pediatric status epilepticus: Barriers to care and outcomes in a real-world setting","volume":"66","author":"Fetta","year":"2025","journal-title":"Epilepsia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1684\/epd.2018.0987","article-title":"Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus","volume":"20","author":"Rao","year":"2018","journal-title":"Epileptic Disord."},{"key":"ref_25","unstructured":"Ludwig, A., and Li, P. (2023, January 1\u20135). The Effects of Levetiracetam Dosing in Convulsive Status Epilepticus: A Retrospective Analysis. In Proceedings of AES Annual Meeting, Orlando, FL, USA."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/cts.2022.302","article-title":"508 Comparing effectiveness and safety of levetiracetam loading doses among patients with status epilepticus","volume":"6","author":"Barnes","year":"2022","journal-title":"J. Clin. Transl. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/5940\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:57Z","timestamp":1760034837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/5940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":29,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14175940"],"URL":"https:\/\/doi.org\/10.3390\/jcm14175940","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}